Page last updated: 2024-10-25

cimetidine and Retroperitoneal Fibrosis

cimetidine has been researched along with Retroperitoneal Fibrosis in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Retroperitoneal Fibrosis: A slowly progressive condition of unknown etiology, characterized by deposition of fibrous tissue in the retroperitoneal space compressing the ureters, great vessels, bile duct, and other structures. When associated with abdominal aortic aneurysm, it may be called chronic periaortitis or inflammatory perianeurysmal fibrosis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Riedl, CR1
Zinnbauer, B1

Other Studies

1 other study available for cimetidine and Retroperitoneal Fibrosis

ArticleYear
[Asynchronous bilateral hydronephrosis in retroperitoneal fibrosis with an interval of 44 months].
    Der Urologe. Ausg. A, 1995, Volume: 34, Issue:1

    Topics: Cimetidine; Duodenal Ulcer; Follow-Up Studies; Humans; Hydronephrosis; Male; Middle Aged; Postoperat

1995